0
Abstract: Poster Presentations |

EFFECT OF ANTI-PLATELET/ANTI-COAGULATION (AC) THERAPY IN PATIENTS WITH GIB REQUIRING ICU ADMISSION FREE TO VIEW

Amir Akhzari, MD*; Vladimir Sabayev, MD; Amreen Dinani, MD
Author and Funding Information

New York Hospital Medical Center of Queens, Flushing, NY


Chest


Chest. 2009;136(4_MeetingAbstracts):26S. doi:10.1378/chest.136.4_MeetingAbstracts.26S-a
Text Size: A A A
Published online

Abstract

PURPOSE:  Given the increasing number of patients on Anti-platelet/Anti-coagulation therapy we aimed to evaluate outcome (mortality, morbidity & length of stay) in cohort with gastrointestinal bleeding requiring ICU admission.

METHODS:  We reviewed 48 patients admitted with the diagnoses of GIB, to the medical ICU. All patients had a primary diagnosis of GIB. The charts were reviewed for demographics (age, sex, PMH), initial platelet count, INR, use of Anti-platelet therapy (Aspirin or Plavix) and/or use of Anti-coagulation therapy (Coumadin), prior to hospitalization. Patients were divided into 3 groups based on platelet/AC therapy; Group 1 consisted of 26 patients on no anti-platelet/AC, group 2 had 15 patients on anti-platelet therapy, and group 3 consisted of 7 patients on AC +/− anti-platelet therapy. Mortality, overall hospital LOS, transfusion requirements, need for intubation and vasopressers were evaluated.

RESULTS:  Patients were analyzed in 3 groups (see table 2). Compared to group 1, patients in the AC group (group 3) had increased need for PRBC (6.6 units/pt vs. 3.6 units/pt), FFP (6.3 units/pt vs. 1.2 units/pt), and LOS (10 days vs. 6.2 days). Patients in the anti-platelet group (group 2) had similar outcomes to group 1, with LOS (5.1 days vs. 6.3 days), PRBC requirement of 2.4units/pt vs. 3.6 units/pt. Between the 3 groups, there were no significant differences in mortality, respiratory failure and shock.

CONCLUSION:  We found that patients admitted to the MICU with the diagnoses of GIB on Anti-coagulation therapy require higher number of PRBC and FFP compared to patients not on Coumadin. Prior administration of Anti-platelet therapy did not affect transfusion requirements and LOS.

CLINICAL IMPLICATIONS:  ICU patients with GIB on Coumadin, but not Anti-platelet therapy, have higher transfusion requirement and higher LOS.

DISCLOSURE:  Amir Akhzari, No Financial Disclosure Information; No Product/Research Disclosure Information

Tuesday, November 3, 2009

12:45 PM - 2:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543